{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:20:45Z","timestamp":1790274045934,"version":"4.1.0"},"reference-count":112,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T00:00:00Z","timestamp":1637539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["2019-2020"],"award-info":[{"award-number":["2019-2020"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Activating mutations in the Hh pathway underlies the development of sporadic and familial skin BCC. For these oncogenic proliferations displaying ligand-independent activation of the intracellular pathway, two molecules have been approved for therapeutic purposes: vismodegib and sonidegib. Improper Hh signalling occurs in many human tumours also via a paracrine mechanism (ligand-dependent) in which the secretion of Hh ligands by stromal cells support tumour growth. On the other hand, the mobilization of neoplastic stroma by cancer cells is sustained by the activation of Hh signalling in surrounding fibroblasts suggesting a central role of this bidirectional crosstalk in carcinogenesis. Additionally, loss-of-function mutations in the PTCH1 gene in the context of NBCCS, an autosomal dominant disorder predisposing to multiple BCCs, determine tumour permissive phenotypes in dermal fibroblasts. Here, profiling syndromic and BCC-associated fibroblasts unveiled an extraordinary similarity characterized by overexpression of several Hh target genes and a marked pro-inflammatory outline. Both cell types exposed to Hh inhibitors displayed reversion of the tumour-prone phenotype. Under vismodegib and sonidegib treatment, the Wnt\/\u03b2-catenin pathway, frequently over-active in tumour stroma, resulted down-regulated by pAKT-GSK3\u03b2 axis and consequent increase of \u03b2-catenin turnover. Overall, this study demonstrated that vismodegib and sonidegib impacting on fibroblast tumour supportive functions might be considered in therapy for BCC independently to the mutation status of Hh components in neoplastic cells.<\/jats:p>","DOI":"10.3390\/cancers13225858","type":"journal-article","created":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T02:55:17Z","timestamp":1637636117000},"page":"5858","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Evaluation of Hedgehog Pathway Inhibition on Nevoid Basal Cell Carcinoma Syndrome Fibroblasts and Basal Cell Carcinoma-Associated Fibroblasts: Are Vismodegib and Sonidegib Useful to Target Cancer-Prone Fibroblasts?"],"prefix":"10.3390","volume":"13","author":[{"given":"Laura","family":"Eibenschutz","sequence":"first","affiliation":[{"name":"Oncologic and Preventative Dermatology, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Caputo","sequence":"additional","affiliation":[{"name":"Laboratory of Cutaneous Physiopathology and Integrated Center of Metabolomics Research, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6633-0449","authenticated-orcid":false,"given":"Emanuela","family":"Camera","sequence":"additional","affiliation":[{"name":"Laboratory of Cutaneous Physiopathology and Integrated Center of Metabolomics Research, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6358-4347","authenticated-orcid":false,"given":"Anna","family":"Carbone","sequence":"additional","affiliation":[{"name":"Oncologic and Preventative Dermatology, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitaliano","family":"Silipo","sequence":"additional","affiliation":[{"name":"Oncologic and Preventative Dermatology, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5316-8937","authenticated-orcid":false,"given":"Emilia","family":"Migliano","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Aurizi","sequence":"additional","affiliation":[{"name":"Department of Dermatological Clinic, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Cota","sequence":"additional","affiliation":[{"name":"Department of Dermophatology, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5592-8485","authenticated-orcid":false,"given":"Pasquale","family":"Frascione","sequence":"additional","affiliation":[{"name":"Oncologic and Preventative Dermatology, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3883-5500","authenticated-orcid":false,"given":"Barbara","family":"Bellei","sequence":"additional","affiliation":[{"name":"Laboratory of Cutaneous Physiopathology and Integrated Center of Metabolomics Research, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1002\/ijc.22952","article-title":"Trends in Incidence of Skin Basal Cell Carcinoma. Additional Evidence from a UK Primary Care Database Study","volume":"121","author":"Smith","year":"2007","journal-title":"Int. J. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2133.2008.08666.x","article-title":"Guidelines for the Management of Basal Cell Carcinoma","volume":"159","author":"Telfer","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/jamadermatol.2013.5870","article-title":"Assessing Health-Related Quality of Life for Advanced Basal Cell Carcinoma and Basal Cell Carcinoma Nevus Syndrome: Development of the First Disease-Specific Patient-Reported Outcome Questionnaires","volume":"150","author":"Mathias","year":"2014","journal-title":"JAMA Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1158\/1078-0432.CCR-20-3715","article-title":"Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer","volume":"27","author":"Steele","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.chembiol.2017.02.010","article-title":"Hedgehog Signaling: From Basic Biology to Cancer Therapy","volume":"24","author":"Wu","year":"2017","journal-title":"Cell. Chem. Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"7852","DOI":"10.1038\/sj.onc.1203243","article-title":"Gli Genes in Development and Cancer","volume":"18","author":"Matise","year":"1999","journal-title":"Oncogene"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/sj.onc.1207240","article-title":"The Zinc-Finger Transcription Factor GLI2 Antagonizes Contact Inhibition and Differentiation of Human Epidermal Cells","volume":"23","author":"Regl","year":"2004","journal-title":"Oncogene"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ejca.2005.08.039","article-title":"GLI Transcription Factors: Mediators of Oncogenic Hedgehog Signalling","volume":"42","author":"Kasper","year":"2006","journal-title":"Eur. J. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1074\/jbc.M310589200","article-title":"Transcriptional Regulation of Bcl-2 Mediated by the Sonic Hedgehog Signaling Pathway through Gli-1","volume":"279","author":"Bigelow","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3389\/fgene.2019.00711","article-title":"Wnt, Notch, and TGF-\u03b2 Pathways Impinge on Hedgehog Signaling Complexity: An Open Window on Cancer","volume":"10","author":"Pelullo","year":"2019","journal-title":"Front. Genet."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1016\/j.jid.2017.07.816","article-title":"Skin-Derived Vitamin D(3) Protects Against Basal Cell Carcinoma","volume":"137","author":"Bijlsma","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1080\/10428194.2018.1493727","article-title":"Targeting the Cross-Talk between the Hedgehog and NF-\u03baB Signaling Pathways in Multiple Myeloma","volume":"60","author":"Cai","year":"2019","journal-title":"Leuk. Lymphoma"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrc3079","article-title":"The Hedgehog\u2019s Tale: Developing Strategies for Targeting Cancer","volume":"11","author":"Ng","year":"2011","journal-title":"Nat. Rev. Cancer."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nrc2503","article-title":"Basal cell carcinomas: Attack of the hedgehog","volume":"10","author":"Epstein","year":"2008","journal-title":"Nat. Rev. Cancer."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/sj.onc.1202360","article-title":"A Frequent Activated Smoothened Mutation in Sporadic Basal Cell Carcinomas","volume":"18","author":"Lam","year":"1999","journal-title":"Oncogene"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/ng.3525","article-title":"Genomic Analysis Identifies New Drivers and Progression Pathways in Skin Basal Cell Carcinoma","volume":"48","author":"Bonilla","year":"2016","journal-title":"Nat. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1038\/modpathol.3800512","article-title":"Basal Cell Carcinoma: Biology, Morphology and Clinical Implications","volume":"19","author":"Crowson","year":"2006","journal-title":"Mod. Pathol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1038\/sj.jid.5700923","article-title":"UV Fingerprints Predominate in the PTCH Mutation Spectra of Basal Cell Carcinomas Independent of Clinical Phenotype","volume":"127","author":"Heitzer","year":"2007","journal-title":"J. Investig. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/bjc.2014.421","article-title":"Inhibition of Hedgehog Signalling by NVP-LDE225 (Erismodegib) Interferes with Growth and Invasion of Human Renal Cell Carcinoma Cells","volume":"111","author":"Rosa","year":"2014","journal-title":"Br. J. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"563838","DOI":"10.3389\/fonc.2020.563838","article-title":"Inhibition of CAL27 Oral Squamous Carcinoma Cell by Targeting Hedgehog Pathway with Vismodegib or Itraconazole","volume":"10","author":"Freitas","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"9250","DOI":"10.18632\/oncotarget.7062","article-title":"In Vitro and in Vivo Inhibition of Breast Cancer Cell Growth by Targeting the Hedgehog\/GLI Pathway with SMO (GDC-0449) Or GLI (GANT-61) Inhibitors","volume":"7","author":"Benvenuto","year":"2016","journal-title":"Oncotarget"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1358\/dnp.2003.16.10.829296","article-title":"Hedgehog Signaling Pathway as a Target for Therapeutic Intervention in Basal Cell Carcinoma","volume":"16","author":"Williams","year":"2003","journal-title":"Drug News. Perspect."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/jmg.2009.068403","article-title":"Phenotype and Genotype in 17 Patients with Goltz-Gorlin Syndrome","volume":"46","author":"Maas","year":"2009","journal-title":"J. Med. Genet."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Onodera, S., Saito, A., Hasegawa, D., Morita, N., Watanabe, K., Nomura, T., Shibahara, T., Ohba, S., Yamaguchi, A., and Azuma, T. (2017). Multi-Layered Mutation in Hedgehog-Related Genes in Gorlin Syndrome may Affect the Phenotype. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0184702"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1126\/science.272.5268.1668","article-title":"Human Homolog of Patched, a Candidate Gene for the Basal Cell Nevus Syndrome","volume":"272","author":"Johnson","year":"1996","journal-title":"Science"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/bjc.1991.435","article-title":"The Incidence of Gorlin Syndrome in 173 Consecutive Cases of Medulloblastoma","volume":"64","author":"Evans","year":"1991","journal-title":"Br. J. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/(SICI)1096-8628(19970331)69:3<299::AID-AJMG16>3.0.CO;2-M","article-title":"Clinical Manifestations in 105 Persons with Nevoid Basal Cell Carcinoma Syndrome","volume":"69","author":"Kimonis","year":"1997","journal-title":"Am. J. Med. Genet."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/ajmg.1320500312","article-title":"Nevoid Basal Cell Carcinoma Syndrome: Review of 118 Affected Individuals","volume":"50","author":"Shanley","year":"1994","journal-title":"Am. J. Med. Genet."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1750-1172-3-32","article-title":"Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome)","volume":"3","year":"2008","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/1523-1747.ep12371786","article-title":"Chromosome 9 Allele Loss Occurs in both Basal and Squamous Cell Carcinomas of the Skin","volume":"102","author":"Quinn","year":"1994","journal-title":"J. Investig. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/S1470-2045(16)30566-6","article-title":"Inhibition of the Hedgehog Pathway in Patients with Basal-Cell Nevus Syndrome: Final Results from the Multicentre, Randomised, Double-Blind, Placebo-Controlled, Phase 2 Trial","volume":"17","author":"Tang","year":"2016","journal-title":"Lancet Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/jid.2011.48","article-title":"Topical Treatment of Basal Cell Carcinomas in Nevoid Basal Cell Carcinoma Syndrome with a Smoothened Inhibitor","volume":"131","author":"Skvara","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jaad.2015.03.021","article-title":"Pivotal ERIVANCE Basal Cell Carcinoma (BCC) Study: 12-Month Update of Efficacy and Safety of Vismodegib in Advanced BCC","volume":"72","author":"Sekulic","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.jid.2017.09.048","article-title":"Genomic Stability in Syndromic Basal Cell Carcinoma","volume":"138","author":"Chiang","year":"2018","journal-title":"J. Invest. Dermatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ccell.2015.02.001","article-title":"Genomic Analysis of Smoothened Inhibitor Resistance in Basal Cell Carcinoma","volume":"27","author":"Sharpe","year":"2015","journal-title":"Cancer. Cell."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jid.2017.11.013","article-title":"Illuminating Alternative Strategies to Treat Targeted Chemotherapy-Resistant Sporadic Basal Cell Carcinoma","volume":"138","author":"Nguyen","year":"2018","journal-title":"J. Investig. Dermatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.critrevonc.2015.11.006","article-title":"Vismodegib, Itraconazole and Sonidegib as Hedgehog Pathway Inhibitors and their Relative Competencies in the Treatment of Basal Cell Carcinomas","volume":"98","author":"Wahid","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ccell.2015.02.002","article-title":"Smoothened Variants Explain the Majority of Drug Resistance in Basal Cell Carcinoma","volume":"27","author":"Atwood","year":"2015","journal-title":"Cancer Cell."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1158\/1078-0432.CCR-15-1588","article-title":"An Investigator-Initiated Open-Label Trial of Sonidegib in Advanced Basal Cell Carcinoma Patients Resistant to Vismodegib","volume":"22","author":"Danial","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"582866","DOI":"10.3389\/fonc.2020.582866","article-title":"Sonidegib for the Treatment of Advanced Basal Cell Carcinoma","volume":"10","author":"Brancaccio","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1111\/jdv.16230","article-title":"Sonidegib and Vismodegib in the Treatment of Patients with Locally Advanced Basal Cell Carcinoma: A Joint Expert Opinion","volume":"34","author":"Dummer","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00280-014-2468-y","article-title":"Absorption, Distribution, Metabolism, and Excretion (ADME) of \u00b9\u2074C-Sonidegib (LDE225) in Healthy Volunteers","volume":"74","author":"Zollinger","year":"2014","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13046-020-01611-0","article-title":"Regulation of Heterogeneous Cancer-Associated Fibroblasts: The Molecular Pathology of Activated Signaling Pathways","volume":"39","author":"Yoshida","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Bellei, B., Migliano, E., and Picardo, M. (2020). A Framework of Major Tumor-Promoting Signal Transduction Pathways Implicated in Melanoma-Fibroblast Dialogue. Cancers, 12.","DOI":"10.3390\/cancers12113400"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","article-title":"The Biology and Function of Fibroblasts in Cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat. Rev. Cancer."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.apsb.2020.10.022","article-title":"Hedgehog Signaling in Gastrointestinal Carcinogenesis and the Gastrointestinal Tumor Microenvironment","volume":"11","author":"Zhang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Takabatake, K., Shimo, T., Murakami, J., Anqi, C., Kawai, H., Yoshida, S., Wathone Oo, M., Haruka, O., Sukegawa, S., and Tsujigiwa, H. (2019). The Role of Sonic Hedgehog Signaling in the Tumor Microenvironment of Oral Squamous Cell Carcinoma. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20225779"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3892\/ijo.2016.3779","article-title":"Prometastatic Mechanisms of CAF-Mediated EMT Regulation in Pancreatic Cancer Cells","volume":"50","author":"Shan","year":"2017","journal-title":"Int. J. Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1158\/1078-0432.CCR-09-1913","article-title":"Overexpression of Smoothened Activates the Sonic Hedgehog Signaling Pathway in Pancreatic Cancer-Associated Fibroblasts","volume":"16","author":"Walter","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Valin, A., Barnay-Verdier, S., Robert, T., Ripoche, H., Brellier, F., Chevallier-Lagente, O., Avril, M.F., and Magnaldo, T. (2009). PTCH1 +\/\u2212 Dermal Fibroblasts Isolated from Healthy Skin of Gorlin Syndrome Patients Exhibit Features of Carcinoma Associated Fibroblasts. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0004818"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Gache, Y., Brellier, F., Rouanet, S., Al-Qaraghuli, S., Goncalves-Maia, M., Burty-Valin, E., Barnay, S., Scarzello, S., Ruat, M., and Sevenet, N. (2015). Basal Cell Carcinoma in Gorlin\u2019s Patients: A Matter of Fibroblasts-Led Protumoral Microenvironment?. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0145369"},{"key":"ref_52","first-page":"471","article-title":"PTCH1 Germline Mutations and the Basaloid Follicular Hamartoma Values in the Tumor Spectrum of Basal Cell Carcinoma Syndrome (NBCCS)","volume":"38","author":"Ponti","year":"2018","journal-title":"Anticancer Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/01.gim.0000182879.57182.b4","article-title":"Clinical Testing for the Nevoid Basal Cell Carcinoma Syndrome in a DNA Diagnostic Laboratory","volume":"7","author":"Klein","year":"2005","journal-title":"Genet. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/1098-1004(200007)16:1<43::AID-HUMU8>3.0.CO;2-7","article-title":"The Spectrum of Patched Mutations in a Collection of Australian Basal Cell Carcinomas","volume":"16","author":"Evans","year":"2000","journal-title":"Hum. Mutat."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.bbalip.2018.04.002","article-title":"Genetic Variation in Human Carboxylesterase CES1 Confers Resistance to Hepatic Steatosis. Biochim. Biophys","volume":"1863","author":"Lian","year":"2018","journal-title":"Acta Mol. Cell. Biol. Lipids"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/exd.12267","article-title":"A Non-Coding Mutation in the 5\u2032 Untranslated Region of Patched Homologue 1 Predisposes to Basal Cell Carcinoma","volume":"22","author":"Tietze","year":"2013","journal-title":"Exp. Dermatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1080\/15476286.2015.1008929","article-title":"Regulation of Human PTCH1b Expression by Different 5\u2032 Untranslated Region Cis-Regulatory Elements","volume":"12","author":"Bisio","year":"2015","journal-title":"RNA Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3892\/mmr.2013.1333","article-title":"Altered Expression of PTCH and HHIP in Gastric Cancer through their Gene Promoter Methylation: Novel Targets for Gastric Cancer","volume":"7","author":"Song","year":"2013","journal-title":"Mol. Med. Rep."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/17611","article-title":"Vertebrate Hedgehog Signalling Modulated by Induction of a Hedgehog-Binding Protein","volume":"397","author":"Chuang","year":"1999","journal-title":"Nature"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/carcin\/bgaa085","article-title":"Downregulation of Hedgehog-Interacting Protein (HHIP) Contributes to Hexavalent Chromium-Induced Malignant Transformation of Human Bronchial Epithelial Cells","volume":"42","author":"Li","year":"2021","journal-title":"Carcinogenesis"},{"key":"ref_61","first-page":"2424","article-title":"HHIP Gene Overexpression Inhibits the Growth, Migration and Invasion of Human Liver Cancer Cells","volume":"25","author":"Wang","year":"2020","journal-title":"J. BUON"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/bjc.2015.2","article-title":"Downregulation of MTSS1 Expression is an Independent Prognosticator in Squamous Cell Carcinoma of the Lung","volume":"112","author":"Kayser","year":"2015","journal-title":"Br. J. Cancer"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1038\/ncomms4465","article-title":"MTSS1 is a Metastasis Driver in a Subset of Human Melanomas","volume":"5","author":"Mertz","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1479-5876-9-95","article-title":"The Impact of Metastasis Suppressor-1, MTSS1, on Oesophageal Squamous Cell Carcinoma and its Clinical Significance","volume":"9","author":"Xie","year":"2011","journal-title":"J. Transl. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1101\/gad.1221804","article-title":"MIM\/BEG4, a Sonic Hedgehog-Responsive Gene that Potentiates Gli-Dependent Transcription","volume":"18","author":"Callahan","year":"2004","journal-title":"Genes Dev."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/jcp.2010.084657","article-title":"Carboxylesterase 1 (Ces1): From Monocyte Marker to Major Player","volume":"64","author":"Markey","year":"2011","journal-title":"J. Clin. Pathol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1242\/dev.124.13.2537","article-title":"Gli1 is a Target of Sonic Hedgehog that Induces Ventral Neural Tube Development","volume":"124","author":"Lee","year":"1997","journal-title":"Development"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/labinvest.2015.144","article-title":"The Evolving Roles of Canonical WNT Signaling in Stem Cells and Tumorigenesis: Implications in Targeted Cancer Therapies","volume":"96","author":"Yang","year":"2016","journal-title":"Lab. Invest."},{"key":"ref_69","first-page":"1019","article-title":"Hedgehog Signaling Pathway and Gastrointestinal Stem Cell Signaling Network (Review)","volume":"18","author":"Katoh","year":"2006","journal-title":"Int. J. Mol. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1242\/jcs.026096","article-title":"Beyond Wnt Inhibition: New Functions of Secreted Frizzled-Related Proteins in Development and Disease","volume":"121","author":"Bovolenta","year":"2008","journal-title":"J. Cell. Sci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.tips.2009.03.007","article-title":"Mechanisms of Hedgehog Pathway Activation in Cancer and Implications for Therapy","volume":"30","author":"Scales","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1021\/ml1000307","article-title":"Discovery of NVP-LDE225, a Potent and Selective Smoothened Antagonist","volume":"1","author":"Pan","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/med.21555","article-title":"Design of Hedgehog Pathway Inhibitors for Cancer Treatment","volume":"39","author":"Bariwal","year":"2019","journal-title":"Med. Res. Rev."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"e00214","DOI":"10.1002\/prp2.214","article-title":"Pharmacological Evaluation of a Series of Smoothened Antagonists in Signaling Pathways and After Topical Application in a Depilated Mouse Model","volume":"4","author":"Lauressergues","year":"2016","journal-title":"Pharmacol. Res. Perspect."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1073\/pnas.0700776104","article-title":"Melanomas Require HEDGEHOG-GLI Signaling Regulated by Interactions between GLI1 and the RAS-MEK\/AKT Pathways","volume":"104","author":"Stecca","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"7659","DOI":"10.1158\/1078-0432.CCR-08-1414","article-title":"Role of Hedgehog Signaling in Ovarian Cancer","volume":"14","author":"Bhattacharya","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1158\/1078-0432.CCR-13-1710","article-title":"A Phase I, Multicenter, Open-Label, First-in-Human, Dose-Escalation Study of the Oral Smoothened Inhibitor Sonidegib (LDE225) in Patients with Advanced Solid Tumors","volume":"20","author":"Rodon","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature02962","article-title":"Hedgehog Signalling in Prostate Regeneration, Neoplasia and Metastasis","volume":"431","author":"Karhadkar","year":"2004","journal-title":"Nature"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nature02009","article-title":"Hedgehog is an Early and Late Mediator of Pancreatic Cancer Tumorigenesis","volume":"425","author":"Thayer","year":"2003","journal-title":"Nature"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"6442","DOI":"10.1038\/sj.onc.1210467","article-title":"Loss of Suppressor-of-Fused Function Promotes Tumorigenesis","volume":"26","author":"Lee","year":"2007","journal-title":"Oncogene"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.febslet.2008.12.010","article-title":"Identification of the Gene Transcription Repressor Domain of Gli3","volume":"583","author":"Tsanev","year":"2009","journal-title":"FEBS Lett."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1242\/dev.126.17.3915","article-title":"Regulation of Gli2 and Gli3 Activities by an Amino-Terminal Repression Domain: Implication of Gli2 and Gli3 as Primary Mediators of Shh Signaling","volume":"126","author":"Sasaki","year":"1999","journal-title":"Development"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Smelkinson, M.G. (2017). The Hedgehog Signaling Pathway Emerges as a Pathogenic Target. J. Dev. Biol., 5.","DOI":"10.3390\/jdb5040014"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"6709","DOI":"10.1038\/ncomms7709","article-title":"Ptch1 and Gli Regulate Shh Signalling Dynamics Via Multiple Mechanisms","volume":"6","author":"Cohen","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nsmb.1632","article-title":"The Structure of SHH in Complex with HHIP Reveals a Recognition Role for the Shh Pseudo Active Site in Signaling","volume":"16","author":"Bosanac","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1242\/dev.095083","article-title":"Essential Role for Ligand-Dependent Feedback Antagonism of Vertebrate Hedgehog Signaling by PTCH1, PTCH2 and HHIP1 during Neural Patterning","volume":"140","author":"Holtz","year":"2013","journal-title":"Development"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1101\/gad.1026303","article-title":"Feedback Control of Mammalian Hedgehog Signaling by the Hedgehog-Binding Protein, Hip1, Modulates Fgf Signaling during Branching Morphogenesis of the Lung","volume":"17","author":"Chuang","year":"2003","journal-title":"Genes Dev."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"77385","DOI":"10.18632\/oncotarget.20485","article-title":"Effects of Photodynamic Therapy on Dermal Fibroblasts from Xeroderma Pigmentosum and Gorlin-Goltz Syndrome Patients","volume":"8","author":"Larcher","year":"2017","journal-title":"Oncotarget"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.yexcr.2017.03.054","article-title":"Hedgehog Signaling Contributes to Basic Fibroblast Growth Factor-Regulated Fibroblast Migration","volume":"355","author":"Zhu","year":"2017","journal-title":"Exp. Cell Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2147\/OTT.S130910","article-title":"Sonidegib: Mechanism of Action, Pharmacology, and Clinical Utility for Advanced Basal Cell Carcinomas","volume":"10","author":"Jain","year":"2017","journal-title":"OncoTargets Ther."},{"key":"ref_91","first-page":"3282","article-title":"Significance of Macrophage Chemoattractant Protein-1 in Macrophage Recruitment, Angiogenesis, and Survival in Human Breast Cancer","volume":"6","author":"Ueno","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature10138","article-title":"CCL2 Recruits Inflammatory Monocytes to Facilitate Breast-Tumour Metastasis","volume":"475","author":"Qian","year":"2011","journal-title":"Nature"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.1073\/pnas.0813203106","article-title":"Hedgehog Signaling is Restricted to the Stromal Compartment during Pancreatic Carcinogenesis","volume":"106","author":"Tian","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","article-title":"Turning Foes to Friends: Targeting Cancer-Associated Fibroblasts","volume":"18","author":"Chen","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"10204","DOI":"10.1038\/ncomms10204","article-title":"Epigenetic Switch Drives the Conversion of Fibroblasts into Proinvasive Cancer-Associated Fibroblasts","volume":"6","author":"Albrengues","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"17845","DOI":"10.1038\/s41598-017-18232-x","article-title":"Global Inactivation of Carboxylesterase 1 (Ces1\/Ces1g) Protects Against Atherosclerosis in Ldlr (-\/-) Mice","volume":"7","author":"Xu","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e20304","DOI":"10.7554\/eLife.20304","article-title":"Cholesterol Activates the G-Protein Coupled Receptor Smoothened to Promote Hedgehog Signaling","volume":"5","author":"Luchetti","year":"2016","journal-title":"Elife"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"e50051","DOI":"10.7554\/eLife.50051","article-title":"Cholesterol Accessibility at the Ciliary Membrane Controls Hedgehog Signaling","volume":"8","author":"Kinnebrew","year":"2019","journal-title":"Elife"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Raleigh, D.R., Sever, N., Choksi, P.K., Sigg, M.A., Hines, K.M., Thompson, B.M., Elnatan, D., Jaishankar, P., Bisignano, P., and Garcia-Gonzalo, F.R. (2018). Cilia-Associated Oxysterols Activate Smoothened. Mol. Cell, 72.","DOI":"10.1016\/j.molcel.2018.08.034"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Blassberg, R., and Jacob, J. (2017). Lipid Metabolism Fattens Up Hedgehog Signaling. BMC Biol., 15.","DOI":"10.1186\/s12915-017-0442-y"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/s41589-020-00678-2","article-title":"Cholesterol Access in Cellular Membranes Controls Hedgehog Signaling","volume":"16","author":"Radhakrishnan","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1021\/bi002487u","article-title":"Enhanced Potency of Human Sonic Hedgehog by Hydrophobic Modification","volume":"40","author":"Taylor","year":"2001","journal-title":"Biochemistry"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"14037","DOI":"10.1074\/jbc.273.22.14037","article-title":"Identification of a Palmitic Acid-Modified Form of Human Sonic Hedgehog","volume":"273","author":"Pepinsky","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Sekulic, A., Migden, M.R., Basset-Seguin, N., Garbe, C., Gesierich, A., Lao, C.D., Miller, C., Mortier, L., Murrell, D.F., and Hamid, O. (2017). Long-Term Safety and Efficacy of Vismodegib in Patients with Advanced Basal Cell Carcinoma: Final Update of the Pivotal ERIVANCE BCC Study. BMC Cancer, 17.","DOI":"10.1186\/s12885-017-3286-5"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/jdv.14542","article-title":"Long-Term Efficacy and Safety of Sonidegib in Patients with Locally Advanced and Metastatic Basal Cell Carcinoma: 30-Month Analysis of the Randomized Phase 2 BOLT Study","volume":"32","author":"Lear","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"156","DOI":"10.36849\/JDD.5657","article-title":"A Review of Hedgehog Inhibitors Sonidegib and Vismodegib for Treatment of Advanced Basal Cell Carcinoma","volume":"20","author":"Migden","year":"2021","journal-title":"J. Drugs Dermatol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/bjd.18552","article-title":"Long-Term Efficacy and Safety of Sonidegib in Patients with Advanced Basal Cell Carcinoma: 42-Month Analysis of the Phase II Randomized, Double-Blind BOLT Study","volume":"182","author":"Dummer","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Passarelli, A., Galdo, G., Aieta, M., Fabrizio, T., Villonio, A., and Conca, R. (2020). A Vismodegib Experience in Elderly Patients with Basal Cell Carcinoma: Case Reports and Review of the Literature. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21228596"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1158\/1078-0432.CCR-11-0972","article-title":"Pharmacokinetic Dose-Scheduling Study of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Locally Advanced Or Metastatic Solid Tumors","volume":"17","author":"Lorusso","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1365-2125.2012.04281.x","article-title":"Single and Multiple Dose Intravenous and Oral Pharmacokinetics of the Hedgehog Pathway Inhibitor Vismodegib in Healthy Female Subjects","volume":"74","author":"Graham","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Pietrobono, S., and Stecca, B. (2018). Targeting the Oncoprotein Smoothened by Small Molecules: Focus on Novel Acylguanidine Derivatives as Potent Smoothened Inhibitors. Cells, 7.","DOI":"10.3390\/cells7120272"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1073\/pnas.0813373106","article-title":"Hedgehog Signal Transduction by Smoothened: Pharmacologic Evidence for a 2-Step Activation Process","volume":"106","author":"Rohatgi","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/22\/5858\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:34:03Z","timestamp":1760168043000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/22\/5858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,22]]},"references-count":112,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["cancers13225858"],"URL":"https:\/\/doi.org\/10.3390\/cancers13225858","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,22]]}}}